203940-49-2

Upstream product

• 203940-48-1 methyl 4-({[1-(3-hydroxymethylphenyl)-2-nitroethyl]thio}methyl)benzoate 
• 922525-34-6 C₁₂H₁₇NO 
• 209688-43-7 4-methoxyformylbenzyl thioacetate 
• 52010-98-7 3-(hydroxymethyl)benzaldehyde 
• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 140639-94-7 2-(3'-hydroxymethyl)phenyl-1,3-dioxolane 
• 17789-14-9 3-(1,3-dioxolan-2-yl)-phenylbromide 
• 68348-23-2 3-(1,3-dioxolan-2-yl)benzaldehyde 

Downstream Products

• 203940-50-5 methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-hydroxymethylphenyl)ethyl]thio}methyl)benzoate 
• 203940-25-4 (+/-)-methyl 4-{[(2-{4-chlorophenylsulfonylamino}-1-{3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl}ethyl)thio]methyl}benzoate 

Relevant academic research and scientific papers

Synthesis of optically active thromboxane A2 and Leukotriene D4 receptor antagonists

Both (+)- and (-)-4-{[(2-{4-cUorophenylsulfonylamino}-1-{3-[(Q-2-(7-cWoro- 2-quinolyl)-vinyl]phenyl}ethyl)-thio]methyl}benzoic acid (1), Thromboxane A2 and Leukotriene D4 receptor dual antagonist were synthesized. Racemic methyl 4-({[2-amino-1-(3-hydroxym